Achillion hepatitis C drug shows promise in mid-stage study
(Reuters) - Achillion Pharmaceuticals Inc said its experimental hepatitis C drug showed promising interim data in a mid-stage trial, sending its share ...Read more
(Reuters) - Achillion Pharmaceuticals Inc said its experimental hepatitis C drug showed promising interim data in a mid-stage trial, sending its share ...Read more
Johnson & Johnson and Pfizer announced on Monday that they were halting development of a closely watched Alzheimer’s drug after two clinical trials fa ...Read more
A website offering parents advice on vaccines has been ordered to remove information about the MMR jab after claiming it could be linked to autism.Bab ...Read more
(Reuters) - Pfizer Inc has agreed to pay $60.2 million to settle a U.S. government probe of the drugmaker's use of illegal payments to win business ov ...Read more
WASHINGTON — Obama administration officials are getting ready to set up and operate new health insurance markets in about half the states, where local ...Read more
(Reuters) - The U.S. Food and Drug Administration on Friday said it granted 10 drugmakers marketing approvals for the first generic forms of Singulair ...Read more
(Reuters) - Chinese police have detained almost 2,000 people in a nationwide sweep on fake drugs, seizing more than $180 million worth of counterfeit ...Read more
The Lancet “No treatment for the disease of addiction was available there. Once a month or so we marched around for a couple of hours chanting slogans ...Read more
NHS urged to make reduction of problem a priority as overweight and teenage mothers found to be most likely to sufferOne in 10 women who have a baby b ...Read more
(Reuters) - Regeneron Pharmaceuticals Inc said U.S. regulators have denied approval for it to expand use of its Arcalyst drug to prevent gout flares, ...Read more